GR3020668T3 - Substituted 4-phenyl-pyridones and 4-phenyl-2-alkoxypyridines as HMG-CoA reductase inhibitors. - Google Patents
Substituted 4-phenyl-pyridones and 4-phenyl-2-alkoxypyridines as HMG-CoA reductase inhibitors.Info
- Publication number
- GR3020668T3 GR3020668T3 GR960402026T GR960402026T GR3020668T3 GR 3020668 T3 GR3020668 T3 GR 3020668T3 GR 960402026 T GR960402026 T GR 960402026T GR 960402026 T GR960402026 T GR 960402026T GR 3020668 T3 GR3020668 T3 GR 3020668T3
- Authority
- GR
- Greece
- Prior art keywords
- phenyl
- alkoxypyridines
- substituted
- pyridones
- hmg
- Prior art date
Links
- DNUDULSSNHKPHP-UHFFFAOYSA-N 4-phenyl-1h-pyridin-2-one Chemical class C1=NC(O)=CC(C=2C=CC=CC=2)=C1 DNUDULSSNHKPHP-UHFFFAOYSA-N 0.000 title abstract 4
- 229940121710 HMGCoA reductase inhibitor Drugs 0.000 title 1
- 239000002471 hydroxymethylglutaryl coenzyme A reductase inhibitor Substances 0.000 title 1
- 229940096701 plain lipid modifying drug hmg coa reductase inhibitors Drugs 0.000 title 1
- 239000003814 drug Substances 0.000 abstract 4
- 229940079593 drug Drugs 0.000 abstract 2
- 208000031226 Hyperlipidaemia Diseases 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/63—One oxygen atom
- C07D213/64—One oxygen atom attached in position 2 or 6
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
- C07F7/1804—Compounds having Si-O-C linkages
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
- C07F9/576—Six-membered rings
- C07F9/58—Pyridine rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Urology & Nephrology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pyridine Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE4243278 | 1992-12-21 | ||
| DE4321421A DE4321421A1 (de) | 1992-12-21 | 1993-06-28 | Substituierte 4-Phenyl-pyridone und 4-Phenyl-2-alkoxypyridine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GR3020668T3 true GR3020668T3 (en) | 1996-10-31 |
Family
ID=25921579
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GR960402026T GR3020668T3 (en) | 1992-12-21 | 1996-07-31 | Substituted 4-phenyl-pyridones and 4-phenyl-2-alkoxypyridines as HMG-CoA reductase inhibitors. |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US5418243A (el) |
| EP (1) | EP0603649B1 (el) |
| JP (1) | JPH06234741A (el) |
| CN (1) | CN1117965A (el) |
| AT (1) | ATE140226T1 (el) |
| AU (1) | AU660132B2 (el) |
| CA (1) | CA2111778A1 (el) |
| CZ (1) | CZ284093A3 (el) |
| DE (1) | DE59303195D1 (el) |
| DK (1) | DK0603649T3 (el) |
| ES (1) | ES2089687T3 (el) |
| FI (1) | FI935728A (el) |
| GR (1) | GR3020668T3 (el) |
| HU (1) | HUT70150A (el) |
| IL (1) | IL108071A0 (el) |
| MX (1) | MX9308013A (el) |
| NO (1) | NO934706L (el) |
| NZ (1) | NZ250500A (el) |
| PH (1) | PH29953A (el) |
| PL (1) | PL301582A1 (el) |
| SK (1) | SK144893A3 (el) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19627420A1 (de) * | 1996-07-08 | 1998-01-15 | Bayer Ag | 6-(Hydroxymethyl-ethyl)pyridine |
| JP2005126340A (ja) * | 2003-10-22 | 2005-05-19 | Kureha Chem Ind Co Ltd | 置換ピリドン類の製造法、その原料化合物及びその製造方法 |
| AR059898A1 (es) | 2006-03-15 | 2008-05-07 | Janssen Pharmaceutica Nv | Derivados de 3-ciano-piridona 1,4-disustituida y su uso como moduladores alostericos de los receptores mglur2 |
| TW200845978A (en) * | 2007-03-07 | 2008-12-01 | Janssen Pharmaceutica Nv | 3-cyano-4-(4-tetrahydropyran-phenyl)-pyridin-2-one derivatives |
| TW200900065A (en) | 2007-03-07 | 2009-01-01 | Janssen Pharmaceutica Nv | 3-cyano-4-(4-pyridinyloxy-phenyl)-pyridin-2-one derivatives |
| NZ584145A (en) | 2007-09-14 | 2012-03-30 | Ortho Mcneil Janssen Pharm | 1',3'-disubstituted-4-phenyl-3,4,5,6-tetrahydro-2h, 1'h-[1,4'] bipyridinyl-2'-ones |
| EA019085B1 (ru) * | 2007-09-14 | 2014-01-30 | Янссен Фармасьютикалз, Инк. | 1',3-двузамещенные 4-(арил-х-фенил)-1н-пиридин-2-оны |
| EP2205565B1 (en) * | 2007-09-14 | 2013-04-17 | Janssen Pharmaceuticals, Inc. | 1,3-disubstituted-4-phenyl-1 h-pyridin-2-ones |
| MX2010005110A (es) * | 2007-11-14 | 2010-09-09 | Ortho Mcneil Janssen Pharm | Derivados de imidazo[1,2-a]piridina y su uso como moduladores alostericos positivos de los receptores de glutamato metabotropico 2. |
| ES2439291T3 (es) | 2008-09-02 | 2014-01-22 | Janssen Pharmaceuticals, Inc. | Derivados de 3-azabiciclo[3.1.0]hexilo como moduladores de receptores de glutamato metabotrópicos |
| US8697689B2 (en) | 2008-10-16 | 2014-04-15 | Janssen Pharmaceuticals, Inc. | Indole and benzomorpholine derivatives as modulators of metabotropic glutamate receptors |
| MX2011005242A (es) | 2008-11-28 | 2011-09-06 | Ortho Mcneil Janssen Pharm | Derivados de indol y benzoxazina como moduladores de los receptores de glutamato metabotropicos. |
| MY153913A (en) | 2009-05-12 | 2015-04-15 | Janssen Pharmaceuticals Inc | 7-aryl-1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors |
| MY161325A (en) | 2009-05-12 | 2017-04-14 | Janssen Pharmaceuticals Inc | 1, 2, 4-triazolo[4,3-a]pyridine derivatives and their use for the treatment or prevention of neurological and psychiatric disorders |
| CA2760259C (en) | 2009-05-12 | 2018-05-01 | Janssen Pharmaceuticals, Inc. | 1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors |
| ES2536433T3 (es) | 2010-11-08 | 2015-05-25 | Janssen Pharmaceuticals, Inc. | Derivados de 1,2,4-triazolo[4,3-a]piridina y su uso como moduladores alostéricos positivos de receptores mGluR2 |
| JP5852664B2 (ja) | 2010-11-08 | 2016-02-03 | ジヤンセン・フアーマシユーチカルズ・インコーポレーテツド | １，２，４−トリアゾロ［４，３−ａ］ピリジン誘導体およびｍＧｌｕＲ２受容体のポジティブアロステリックモジュレーターとしてのそれらの使用 |
| CN103298809B (zh) | 2010-11-08 | 2016-08-31 | 杨森制药公司 | 1,2,4-三唑并[4,3-a]吡啶衍生物及其作为MGLUR2受体的正变构调节剂的用途 |
| JO3368B1 (ar) | 2013-06-04 | 2019-03-13 | Janssen Pharmaceutica Nv | مركبات 6، 7- ثاني هيدرو بيرازولو [5،1-a] بيرازين- 4 (5 يد)- اون واستخدامها بصفة منظمات تفارغية سلبية لمستقبلات ميجلور 2 |
| JO3367B1 (ar) | 2013-09-06 | 2019-03-13 | Janssen Pharmaceutica Nv | مركبات 2،1، 4- ثلاثي زولو [3،4-a] بيريدين واستخدامها بصفة منظمات تفارغية موجبة لمستقبلات ميجلور 2 |
| ME03518B (me) | 2014-01-21 | 2020-04-20 | Janssen Pharmaceutica Nv | Kombinacije koje obuhvataju pozitivne alosterične modulatore ili ortosterične agoniste metabotropnog glutamatergičnog receptora podtipa 2 i njihova primjena |
| WO2015110435A1 (en) | 2014-01-21 | 2015-07-30 | Janssen Pharmaceutica Nv | Combinations comprising positive allosteric modulators or orthosteric agonists of metabotropic glutamatergic receptor subtype 2 and their use |
| CN104370806B (zh) * | 2014-06-17 | 2017-07-07 | 中国海洋大学 | 一种吡啶酮生物碱类化合物及其制备方法和用途 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4154838A (en) * | 1975-07-31 | 1979-05-15 | Smith Kline & French Laboratories Limited | Alkoxy pyridine |
| GB1564502A (en) * | 1975-07-31 | 1980-04-10 | Smith Kline French Lab | Guanidines thioureas and 1,1-diamino-2-nitroethylene derivatives |
| US4684477A (en) * | 1985-03-06 | 1987-08-04 | Chisso Corporation | Pyridine derivatives and their use in liquid crystals |
| US4906624A (en) * | 1987-09-08 | 1990-03-06 | Warner-Lambert Company | 6-(((Substituted)pyridin-3-yl)alkyl)-and alkenyl)-tetrahydro-4-hydroxypyran-2-one inhibitors of cholesterol biosynthesis |
| EP0339342A1 (de) * | 1988-04-23 | 1989-11-02 | Bayer Ag | N-Substituierte N-Amino-pyrrole |
| US4916239A (en) * | 1988-07-19 | 1990-04-10 | Merck & Co., Inc. | Process for the lactonization of mevinic acids and analogs thereof |
| US5032602A (en) * | 1988-12-14 | 1991-07-16 | Bayer Aktiengesellschaft | Inhibiting HMG-CoA reductase with novel substituted 2-pyridones and pyrid-2-thiones |
| DE3909378A1 (de) * | 1989-03-22 | 1990-09-27 | Bayer Ag | Substituierte biphenyle |
| DE3925636A1 (de) * | 1989-08-03 | 1991-02-07 | Bayer Ag | Imino-substituierte pyridine |
-
1993
- 1993-11-25 AU AU51955/93A patent/AU660132B2/en not_active Ceased
- 1993-12-08 AT AT93119766T patent/ATE140226T1/de not_active IP Right Cessation
- 1993-12-08 DE DE59303195T patent/DE59303195D1/de not_active Expired - Fee Related
- 1993-12-08 ES ES93119766T patent/ES2089687T3/es not_active Expired - Lifetime
- 1993-12-08 DK DK93119766.9T patent/DK0603649T3/da active
- 1993-12-08 EP EP93119766A patent/EP0603649B1/de not_active Expired - Lifetime
- 1993-12-14 US US08/166,775 patent/US5418243A/en not_active Expired - Fee Related
- 1993-12-15 MX MX9308013A patent/MX9308013A/es not_active Application Discontinuation
- 1993-12-17 CA CA002111778A patent/CA2111778A1/en not_active Abandoned
- 1993-12-17 NZ NZ250500A patent/NZ250500A/en unknown
- 1993-12-17 IL IL10807193A patent/IL108071A0/xx unknown
- 1993-12-20 FI FI935728A patent/FI935728A/fi unknown
- 1993-12-20 PH PH47501A patent/PH29953A/en unknown
- 1993-12-20 CZ CZ932840A patent/CZ284093A3/cs unknown
- 1993-12-20 PL PL93301582A patent/PL301582A1/xx unknown
- 1993-12-20 NO NO934706A patent/NO934706L/no unknown
- 1993-12-20 JP JP5344533A patent/JPH06234741A/ja active Pending
- 1993-12-20 SK SK1448-93A patent/SK144893A3/sk unknown
- 1993-12-20 HU HU9303675A patent/HUT70150A/hu unknown
- 1993-12-21 CN CN93112965A patent/CN1117965A/zh active Pending
-
1996
- 1996-07-31 GR GR960402026T patent/GR3020668T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP0603649B1 (de) | 1996-07-10 |
| PH29953A (en) | 1996-09-16 |
| DK0603649T3 (da) | 1996-11-04 |
| EP0603649A1 (de) | 1994-06-29 |
| CA2111778A1 (en) | 1994-06-22 |
| NO934706D0 (no) | 1993-12-20 |
| US5418243A (en) | 1995-05-23 |
| ES2089687T3 (es) | 1996-10-01 |
| CN1117965A (zh) | 1996-03-06 |
| NZ250500A (en) | 1996-02-27 |
| AU5195593A (en) | 1994-06-30 |
| HU9303675D0 (en) | 1994-04-28 |
| PL301582A1 (en) | 1994-06-27 |
| FI935728A0 (fi) | 1993-12-20 |
| ATE140226T1 (de) | 1996-07-15 |
| DE59303195D1 (de) | 1996-08-14 |
| MX9308013A (es) | 1994-08-31 |
| HUT70150A (en) | 1995-09-28 |
| FI935728A (fi) | 1994-06-22 |
| IL108071A0 (en) | 1994-04-12 |
| NO934706L (no) | 1994-06-22 |
| JPH06234741A (ja) | 1994-08-23 |
| AU660132B2 (en) | 1995-06-08 |
| CZ284093A3 (en) | 1994-07-13 |
| SK144893A3 (en) | 1995-02-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GR3020668T3 (en) | Substituted 4-phenyl-pyridones and 4-phenyl-2-alkoxypyridines as HMG-CoA reductase inhibitors. | |
| AU649421B2 (en) | Isoxazole-4-carboxamides and hydroxyalkylidene-cyanoacetamides, drugs containing these compounds and use of such drugs | |
| AU5022593A (en) | Prodrugs, their preparation and use as pharmaceuticals | |
| AU7177794A (en) | Absorption enhancers for drug administration | |
| AU6194694A (en) | Nor-bile acid derivatives, processes for their preparation and the use of these compounds as medicaments | |
| AU3575193A (en) | S-triazine derivative and remedy for estrogen-dependent diseases containing the same as active ingredient | |
| HU9402238D0 (en) | 1-benzenesulfonyl-1,3-dihydro-2h-benzimidazol-2-one derivatives, process for producing them and pharmaceutical compositions containing them | |
| HRP930239A2 (en) | Anti-inflamatory 4-aminophenol derivatives | |
| AU1890295A (en) | Piperidines and pyrrolidines | |
| WO1993000094A3 (en) | Use of tetrahydrobenzazepine derivatives for the treatment of portal hypertension and migraine | |
| CA2078662A1 (en) | 4-desoxy-epipodophyllotoxin derivative or pharmaceutically acceptable salt thereof | |
| HU9402292D0 (en) | New baccatine-iii and 10-deacetyl-baccatine-iii derivatives, process for producing them and pharmaceutical compositions containing them as active component | |
| AU2861389A (en) | Disubstituted pyridines | |
| MY130107A (en) | Piperidylmethyl-substituted chroman derivatives | |
| DE59305147D1 (de) | Substituierte Pyridine als HMG-CoA-Reduktase-Inhitoren | |
| HU9401914D0 (en) | Piperidine- and piperazine derivatives, pharmaceutical compositions containing them as active components and process for producing both | |
| TW245713B (el) | ||
| WO1995022544A3 (de) | Substituierte 1,3,8-triaza-spiro(4,5)-decan-4-on-derivate als vorstufen zur herstellung von pharmazeutika | |
| AU658197B2 (en) | New use of benzimidazoline-2-oxo-1-carboxylic acid derivatives | |
| GR920100423A (el) | Ανταγωνιστές 5-ΗΤ4 κινολιζιδινυλ εστέρος. | |
| HU9403439D0 (en) | Paclitaxel derivatives, process for producing them, and pharmaceutical compositions contraining them as active component |